Xilio Therapeutics Company
Xilio Therapeutics is a biopharmaceutical company focused on developing highly-potent, targeted immuno-oncology therapeutics.
Connections from
Total Funding:
233000000
Headquarters:
Waltham, Massachusetts, United States
Funding Status:
IPO
Employee Number:
11-50
Last Funding Type:
Series C
Founded Date:
2016-01-01
Industry:
PharmTech